Atlas Trials

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Clinical trial NCT02204163 · COMPLETED

Trial details

NCT number
NCT02204163
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prader-Willi Syndrome
Start date
2014-06-01
Primary completion
2017-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.